Personalized and longitudinal electronic informed consent in clinical trials: How to move the needle?
Changes in the clinical trials landscape have been driven by advancements in digital technology. The use of electronic informed consent to inform research participants and to obtain their consent electronically has the potential to improve participant–researcher interactions over time, facilitate cl...
Main Authors: | Evelien De Sutter, Liese Barbier, Pascal Borry, David Geerts, John P.A. Ioannidis, Isabelle Huys |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-01-01
|
Series: | Digital Health |
Online Access: | https://doi.org/10.1177/20552076231222361 |
Similar Items
-
Informing a European guidance framework on electronic informed consent in clinical research: a qualitative study
by: Evelien De Sutter, et al.
Published: (2023-02-01) -
Personalized and long-term electronic informed consent in clinical research: stakeholder views
by: Evelien De Sutter, et al.
Published: (2021-07-01) -
Testing and Practical Implementation of a User-Friendly Personalized and Long-Term Electronic Informed Consent Prototype in Clinical Research: Mixed Methods Study
by: Evelien De Sutter, et al.
Published: (2023-12-01) -
Digitizing the Informed Consent Process: A Review of the Regulatory Landscape in the European Union
by: Evelien De Sutter, et al.
Published: (2022-05-01) -
Implementation of Electronic Informed Consent in Biomedical Research and Stakeholders’ Perspectives: Systematic Review
by: De Sutter, Evelien, et al.
Published: (2020-10-01)